Multimodal method for identifying hazardous agents

• US 7,532,320 B2
• Filed: 11/30/2004
• Issued: 05/12/2009
• Est. Priority Date: 06/30/2004
• Status: Active Grant

• Current Assignee: Chemimage Corporation
• Original Assignee: Chemimage Corporation
• Inventors: Treado, Patrick, Nelson, Matthew P., Schweitzer, Robert, Neiss, Jason
• Primary Examiner(s): Chowdhury; Tarifur
• Assistant Examiner(s): COOK, JONATHON
• Application Number:
  US11/000,841
• Publication Number:
  US 20080192246A1
• Time in Patent Office: 1,624 Days
• Field of Search: 356/72, 356/73, 356/301
• US Class Current: 356/301
• CPC Class Codes: G01J 3/02 Details
• CPC Class Codes: G01J 3/0291 Housings; Spectrometer accessories; Spatial arrangement of elements, e.g. folded path arrangements
• CPC Class Codes: G01J 3/0294 Multi-channel spectroscopy
• CPC Class Codes: G01J 3/4406 Fluorescence spectrometry
• CPC Class Codes: G01N 21/6458 Fluorescence microscopy fluorescence microscopes per se G02B21/0076 and G02B21/16
• CPC Class Codes: G01N 21/65 Raman scattering

Abstract

The invention relates to apparatus and methods for assessing occurrence of a hazardous agent in a sample by performing multimodal spectral analysis of the sample. Methods of employing Raman spectroscopy for entities in a sample which exhibit one or more optical properties characteristic of a hazardous agent are disclosed. Devices and systems suitable for performing such methods are also disclosed.

Claims

1. A method of assessing occurrence of a pathogen in a sample that comprises multiple entities, the method comprising assessing a first optical property of the entities, wherein the first optical property is characteristic of the pathogen, selecting only an entity exhibiting the first optical property and thereafter performing an assessment of Raman-shifted radiation scattered by the selected entity, wherein one or more entities failing to exhibit said first optical property are excluded from said assessment wherein exhibition of a Raman scattering property characteristic of the pathogen by the selected entity is indicative that the pathogen occurs in the sample.

2. The method of claim 1, wherein the first optical property is selected from the group consisting of absorbance, fluorescence, diffraction, polarization, microscopic morphology, and an optical property associated with particle motion.

3. The method of claim 1, wherein the first optical property is microscopic morphology.

4. The method of claim 3, wherein the morphology is assessed by a method selected from the group consisting of scanning electron microscopy, visible light reflectance microscopy, ultraviolet light reflectance microscopy, light reflectance microscopy, visible light transmission microscopy, ultraviolet light transmission microscopy, infrared light transmission microscopy, and fluorescence microscopy.

5. The method of claim 4, wherein the morphology is assessed by visible light reflectance microscopy.

6. The method of claim 1, comprising assessing Raman-shifted radiation scattered by a selected entity that also exhibits a second optical property characteristic of the pathogen.

7. The method of claim 6, wherein the second optical property is selected from the group consisting of absorbance, fluorescence, diffraction, polarization, and microscopic morphology.

8. The method of claim 6, wherein Raman-shifted scattered radiation is assessed only for entities for which the first and second optical properties are characteristic of the pathogen.

9. The method of claim 6, wherein the first optical property is microscopic morphology.

10. The method of claim 9, wherein the second optical property is fluorescence.

11. The method of claim 10, wherein the first and second optical properties are both assessed by fluorescence microscopy.

12. The method of claim 10, wherein the morphology is assessed by visible light reflectance microscopy.

13. The method of claim 10, wherein fluorescence is assessed only for entities that exhibit microscopic morphology characteristic of the pathogen.

14. The method of claim 1, wherein the pathogen is a synthetic organic chemical.

15. The method of claim 1, wherein the pathogen is an inorganic chemical.

16. The method of claim 1, wherein the pathogen is a biological toxin.

17. The method of claim 1, wherein the pathogen is a microorganism.

18. The method of claim 17, wherein the microorganism is a bacterium.

19. The method of claim 17, wherein the microorganism is a protozoan.

20. The method of claim 1, wherein the pathogen is a virus.

21. The method of claim 1, wherein the Raman-shifted scattered radiation is transmitted through a filter prior to assessing the Raman-shifted scattered radiation.

22. The method of claim 21, wherein the filter is selected from the group consisting of a Fabry Perot angle tuned filter, an acousto-optic tunable filter, a liquid crystal tunable filter, a Lyot filter, an Evans split element liquid crystal tunable filter, a Solc liquid crystal tunable filter, a fixed wavelength Fabry Perot tunable filter, an air-tuned Fabry Perot tunable filter, a mechanically-tuned Fabry Perot tunable filter, and a liquid crystal Fabry Perot tunable filter.

23. The method of claim 1, wherein the Raman-shifted scattered radiation is transmitted through an interferometer prior to assessing the Raman-shifted scattered radiation.

24. The method of claim 23, wherein the interferometer is selected from the group consisting of a polarization-independent imaging interferometer, a Michelson interferometer, a Sagnac interferometer, a Twynam-Green interferometer, a Mach-Zehnder interferometer, and a tunable Fabry Perot Interferometer.

25. The method of claim 1, wherein the Raman-shifted scattered radiation is collected using a device selected from the group consisting of a macroscope, a microscope, an endoscope, and a fiber optic array.

26. The method of claim 1, comprising assessing a Raman scattering spectrum of the selected entity.

27. The method of claim 26, wherein the spectrum includes Raman shift values in the range 20-2000 cm⁻

1.

28. The method of claim 26, wherein the spectrum includes Raman shift values in the range 2700-3200 cm⁻

1.

29. The method of claim 26, wherein the spectrum includes Raman shift values in the range 1000-2000 cm⁻

1.

30. The method of claim 26, wherein the spectrum includes Raman shift values in the range 500-3000 cm⁻

1.

31. A device for assessing occurrence of a pathogen in a sample that comprises multiple entities, the device comprising a radiation source for irradiating the sample, a detector for detecting an optical property of the entities, a Raman detector for detecting Raman-shifted radiation scattered by the entities, and a controller operably linked to the Raman detector wherein said controller restricts detection of Raman-shifted radiation only to entities for which the optical property is characteristic of the pathogen.

32. A device for assessing occurrence of a pathogen in an ambient sample, the device comprising an air handling system for depositing particles in the ambient air on a substrate, a radiation source for irradiating the substrate, a detector for detecting an optical property of the particles deposited on the substrate, a Raman detector for detecting Raman-shifted radiation scattered by the particles deposited on the substrate, and a controller operably linked to the Raman detector, wherein said controller restricts detection of Raman-shifted radiation only to particles for which the optical property is characteristic of the pathogen.

33. The device of claim 32, wherein said-device is housed in a backpack.

34. The device of claim 32, further comprising a vapor sensor for continuous air monitoring.

35. The device of claim 32, wherein the air handling system further comprises a vapor sensor for continuous air monitoring.